NCT06683820View on ClinicalTrials.gov

Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques

CompletedOBSERVATIONAL

Enrollment

3

Participants

Timeline

Start Date

April 2, 2023

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions

Hepatocellular Carcinoma (HCC)

Trial Locations (1)

310009

2ndAffiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER